A detailed history of Atom Investors LP transactions in Compugen LTD stock. As of the latest transaction made, Atom Investors LP holds 119,115 shares of CGEN stock, worth $195,348. This represents 0.02% of its overall portfolio holdings.

Number of Shares
119,115
Previous 50,027 138.1%
Holding current value
$195,348
Previous $129,000 55.04%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.68 - $2.52 $116,067 - $174,101
69,088 Added 138.1%
119,115 $200,000
Q1 2024

May 15, 2024

BUY
$1.75 - $2.95 $87,547 - $147,579
50,027 New
50,027 $129,000
Q4 2020

Feb 16, 2021

SELL
$12.07 - $17.95 $1.77 Million - $2.63 Million
-146,343 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$14.16 - $19.45 $184,122 - $252,908
13,003 Added 9.75%
146,343 $2.38 Million
Q2 2020

Aug 14, 2020

BUY
$6.97 - $17.12 $929,379 - $2.28 Million
133,340 New
133,340 $2 Million

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.